Revvity, 3306-001U, GSP Neonatal IRT kit

Overview
The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome. The amount of the pancreatic enzyme, immunoreactive trypsin (ogen) (IRT) has been shown to be increased in blood of CF patients especially during the first weeks after birth.
GSP Neonatal IRT assay:

Linear calibration curve fitting - improved precision
Incubation time 2 h
Sensitive, robust DELFIA chemistry for confidence in results
All reagents are ready to use
The kit contains reagents and plates for 1152 tests (12 plates)

The assay is based on a direct sandwich technique where two monoclonal antibodies bind to different epitopes on the target molecule. The fluorescence signal is proportional to the analyte concentration in the sample. Application-Newborn Screening
Brand-GSP®
Detection Modality-Time-Resolved Fluorescence (TRF)
Disorders-Cystic Fibrosis
Instrument Compatibility-GSP
Quantity-1152 tests
Sample Type-Dried blood spots
Technology-DELFIA
Unit Size-1 kit